7Baggers
 Fabry Disease Therapeutics Market Set for Dynamic Prospective  openPR.com Mon, 17 Nov 2025 09:15:19 GMT
 Published on: 2025-11-15 01:35:48  newser.com Sat, 15 Nov 2025 07:35:48 GMT
 Published on: 2025-11-14 07:58:56  Fundação Cultural do Pará Fri, 14 Nov 2025 10:58:56 GMT
 Published on: 2025-11-13 23:16:15  newser.com Fri, 14 Nov 2025 05:16:15 GMT
 ultragenyx gets $400 million cash infusion, reports 15% rise in sales  The Press Democrat Wed, 12 Nov 2025 00:47:52 GMT
 Ultragenyx gets $400 million cash infusion, reports 15% rise in sales  The Press Democrat Mon, 10 Nov 2025 08:00:00 GMT
 15 stocks set to explode in 2026  Insider Monkey Sun, 09 Nov 2025 22:19:54 GMT
 published on: 2025-11-09 13:40:50  newser.com Sun, 09 Nov 2025 19:40:50 GMT
 chart based analysis of ultragenyx pharmaceutical inc. trends  newser.com Sun, 09 Nov 2025 18:32:08 GMT
 william blair has bearish estimate for rare fy2025 earnings  MarketBeat Sat, 08 Nov 2025 12:25:31 GMT
 leerink partnrs issues pessimistic outlook for rare earnings  MarketBeat Sat, 08 Nov 2025 12:25:29 GMT
 wedbush issues pessimistic estimate for rare earnings  MarketBeat Sat, 08 Nov 2025 12:25:28 GMT
 how ultragenyx pharmaceutical inc. (rare) affects rotational strategy timing  news.stocktradersdaily.com Sat, 08 Nov 2025 11:20:02 GMT
 ultragenyx sells portion of crysvita royalties for $400 million  The Pharma Letter Thu, 06 Nov 2025 16:14:59 GMT
 published on: 2025-11-06 04:42:43  newser.com Thu, 06 Nov 2025 10:42:43 GMT
 td cowen sticks to their buy rating for ultragenyx pharmaceutical (rare)  The Globe and Mail Thu, 06 Nov 2025 08:00:00 GMT
 TD Cowen Updates Ultragenyx Pharmaceutical (RARE) Price Target |  GuruFocus Wed, 05 Nov 2025 19:34:40 GMT
 truist securities lowers price target for ultragenyx pharmaceuti  GuruFocus Wed, 05 Nov 2025 17:45:20 GMT
 Ultragenyx Pharmaceutical Inc. SEC 10-Q Report  TradingView Wed, 05 Nov 2025 11:03:00 GMT
 ultragenyx pharmaceutical q3 2025 earnings call transcript  MarketBeat Wed, 05 Nov 2025 10:44:11 GMT
 ultragenyx: q3 earnings snapshot  CT Insider Wed, 05 Nov 2025 09:40:09 GMT
 ultragenyx pharmaceutical q3 net loss widens, revenue increases  MarketScreener Wed, 05 Nov 2025 08:50:12 GMT
 Ultragenyx Q3 Earnings and Sales Miss Estimates, Increase Y/Y  Yahoo Finance Wed, 05 Nov 2025 08:00:00 GMT
 Ultragenyx Pharmaceutical (NASDAQ:RARE) Posts Earnings Results  MarketBeat Wed, 05 Nov 2025 08:00:00 GMT
 why ultragenyx pharmaceutical shares are under pressure  TipRanks Wed, 05 Nov 2025 08:00:00 GMT
 ultragenyx pharmaceutical inc (rare) q3 2025 earnings call highl  GuruFocus Wed, 05 Nov 2025 05:26:15 GMT
 ultragenyx reports q3 2025 financial results  TipRanks Wed, 05 Nov 2025 04:26:17 GMT
 ultragenyx reports growth and wall street sees more ahead  Finimize Wed, 05 Nov 2025 00:27:03 GMT
 ultragenyx (rare) secures $400m through expanded royalty deal wi  GuruFocus Tue, 04 Nov 2025 23:43:14 GMT
 ultragenyx pharmaceutical q3 2025 earnings call transcript  MarketBeat Tue, 04 Nov 2025 23:15:00 GMT
 ultragenyx tumbles on $400 mln crysvita royalty sale  TradingView Tue, 04 Nov 2025 22:40:53 GMT
 ultragenyx (rare) reports q3 loss, misses revenue estimates  Yahoo Finance Tue, 04 Nov 2025 22:15:03 GMT
 Ultragenyx Pharmaceutical Inc Reports Q3 2025 Earnings: EPS of -  GuruFocus Tue, 04 Nov 2025 21:45:37 GMT
 rare's q3 revenue misses estimates amid strategic advancements  GuruFocus Tue, 04 Nov 2025 21:45:36 GMT
 ultragenyx signs $400m royalty purchase agreement  TipRanks Tue, 04 Nov 2025 21:38:35 GMT
 ultragenyx: q3 earnings snapshot  New Haven Register Tue, 04 Nov 2025 21:11:15 GMT
 rare - ultragenyx pharm latest stock news & market updates  Stock Titan Tue, 04 Nov 2025 21:05:00 GMT
 Ultragenyx Announces Sale of a Portion of Future North  GlobeNewswire Tue, 04 Nov 2025 21:01:00 GMT
 published on: 2025-11-04 05:38:55  newser.com Tue, 04 Nov 2025 11:38:55 GMT

Ultragenyx Pharmaceutical Inc
(NASDAQ:RARE) 

RARE stock logo

Ultragenyx Pharmaceutical Inc., a biopharmaceutical company, focuses on the identification, acquisition, development, and commercialization of novel products for the treatment of rare and ultra-rare genetic diseases in the United States. Its biologic products include Crysvita (burosumab), an antibod...

Founded: 2010
Full Time Employees: 740
Sector: Healthcare
Industry: Biotechnology

Share this website to your friends